AMSA On Call

Go Back

Landmark Ruling on Generic Drugs

Today, India's Supreme Court rejected an application from Novartis AG for a patent on a cancer drug. This is a landmark ruling that will ensure that poor patients worldwide will have access to lifesaving medications.

Novartis' application asked for a new patent to protect its investment in the cancer drug Glivec. India has a large generic drug industry - almost $26 billion - so this decision impacts much of the developing world.

AMSA continues to pressure pharmaceutical companies to provide affordable medicines to developing countries and lobbies to ensure that international trade regulations afford the right to do so.

Read more from the New York Times.

Facebook Twitter DZone It! Digg It! StumbleUpon Technorati NewsVine Reddit Blinklist Add diigo bookmark

Post a comment!
  1. Formatting options

What is AMSA On Call?

AMSA On Call is the official blog of the American Medical Student Association. Join us as we discuss the hottest issues in health care. 

Save the Date

AMSA Convention 2016 Logo

Current Campaigns

AMSA actively focuses on campaigns throughout the year that align with our organization's aspirations, mission and values.

The New Physician (TNP)

The New Physician MagazineRead AMSA's award-winning magazine & past issues.

Follow Us

Follow us on FaceBook Follow us on Twitter AMSA on YouTube AMSA RSS